Glucagon brand name?

See the DrugPatentWatch profile for Glucagon

Why is Glucagon a brand-name medication?

Glucagon is a brand-name medication used to treat severe hypoglycemia (low blood sugar), diabetic coma, and other conditions such as pancreatic trauma. [1] It is a hormone that works by stimulating the liver to release stored glucose into the bloodstream, thereby raising blood sugar levels.

What is the active ingredient in Glucagon?

The active ingredient in Glucagon is glucagon, which is a polypeptide hormone produced by the pancreas. [2] Glucagon is available under the brand name Glucagon from various pharmaceutical companies, including Eli Lilly and Company.

When did Glucagon first receive approval?

Glucagon was first approved by the US FDA in 1943. [3] Since then, it has undergone several formulations, packaging, and dosing changes.

Who makes Glucagon?

Several pharmaceutical companies manufacture Glucagon, including Eli Lilly and Company. [4] These companies have various manufacturing and distribution agreements in place to ensure availability of the medication.

Why are companies challenging Glucagon patents?

As patents for Glucagon expire, companies may challenge existing patents or seek to develop generic versions of the medication. However, these challenges do not necessarily indicate that existing Glucagon formulations are ineffective or inferior.

How does Glucagon compare with other medications?

Glucagon is distinct from other medications used to treat hypoglycemia, such as intravenous IV fluids, glucagon-like peptide-1 (GLP-1) receptor agonists, and glucagon receptor antagonists. Its unique mechanism of action makes it a valuable treatment option for certain patients.

Sources:

[1] National Library of Medicine: MedlinePlus

[2] RxList.com: Glucagon

[3] Drugs.com: Glucagon

[4] Eli Lilly and Company: Glucagon